Refractory Classical Hodgkin Lymphoma Presenting with Atypical Cutaneous Involvement and Diagnosis of ZZ Phenotype Alpha-1 Antitrypsin Deficiency
Figure 3
(a) PET scan at presentation, (b) PET scan done after 6 cycles of AVD, (c) PET scan after 8 cycles of AVD, and (d) PET scan after 2 cycles of brentuximab.